Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy

Leprosy Review

Volumn 80, Issue 2, 2009, Pages 170-176

  Jing, Zhichun ^a   Zhang, Renbao ^a   Zhou, Doahai ^a   Chen, Jiakeun ^a  

^a Shanghai Skin Disease and STD Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; DAPSONE; RIFAMPICIN;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; CONJUNCTIVA DISCOLORATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DRY EYE; EYE DISEASE; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEPATOMEGALY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIBACILLARY LEPROSY; MYCOBACTERIUM LEPRAE; NEUROPATHY; NONHUMAN; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RECURRENT INFECTION; RETREATMENT; SCLERA DISCOLORATION; SIDE EFFECT; SKIN MANIFESTATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; DAPSONE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEPROSTATIC AGENTS; LEPROSY; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RECURRENCE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70349182504     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ji BH, Chen JK, Zhang JL et al. Secondary dapsone-resistant leprosy in Shanghai Municipality. Lepr Rev, 1983; 54: 197-202.
2. MA HD. Handbook of leprosy control. Jiangsu Science and Technology Press, Nanjing, 1989; pp. 250.
3. Tech. Rep. Ser. 847WHO STUDY GROUP. Chemotherapy of leprosy. World Health Organization, Geneva, 1994; Tech. Rep. Ser. 847.
4. Reddy PK, Cherian A. Relapse in Hansen's disease after multidrug therapy and its differential diagnosis with reversal reaction. The Star, WHO Technical Report Series 716, Louisiana, 1991; 50: 8-13.
5. Aranthathi S. Proceeding of Joint Meeting of Indian and Chemotherapy of Leprosy (THELEP) Scientists on MDT in leprosy, SLR & T Centre. Karigiri, 1989; 88-90.
6. Waters MFR. Clinical problem in initiating and assessment of MDT. Lepr Rev, 1986; 57: 92-100.
7. Chen XS, Li WZ, Jiang C et al. Studies on risk of leprosy relapses in China: relapses after treatment with dapsone monotherapy. Int J Lepr, 1999; 67: 371-378. (Pubitemid 30090417)
8. The Leprosy Unit, WHO. Risk of relapse in leprosy. Indian J Lepr, 1995; 67: 13-26.
9. Thomas Bayes. Studies in the History of Probability and Statistics: IX. Thomas Bayes' Essay Towards Solving a Problem in the Doctrine of Chances. Biometrika, 1763/1958; 45: 296-315.
10. Biswas S, Mondal KK. Multidrug therapy in leprosy can prevent relapse-a retrospective study. Indian J Lepr, 2002; 74: 313-318. (Pubitemid 36215710)
11. Colston MT. Persisting Mycobacterium leprae among THELEP trial patients in Bamako and Chingleput. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. Lepr Rev, 1987; 58: 325-337.
12. Thomas A, Haril L, Nagarajan M et al. Relapses during long-term follow up with drug susceptible M. leprae among multibacillary leprosy patients treated with multidrug therapy regiment, case reports. Int J Lepr, 1995; 63: 391-394.
13. Pai W. Relapse after multidrug therapy in leprosy respond to treatment. Int J Lepr, 1998; 66: 16-18.
14. Ali MK, Thorat DM, Subramanian M et al. A study on trend of relapse in leprosy and factors influencing relapse. Indian J Lepr, 2005; 77: 105-115. (Pubitemid 40932678)
15. Shen J, Liu M, Zhang J et al. Relapse in MB leprosy patients treated with 24 months of MDT in south west China: a short report. Lepr Rev, 2006; 77: 219-224. (Pubitemid 44901765)
16. Jamet P, Ji B. Relapse after long-term follow up of multibacillary patients treated by WHO multidrug regimen. Marchoux Chemotherapy Study Group. Int J Lepr, 1995; 63: 195-201.
17. Maganjeet, Bharti R. Relapse, reinfection or inadequate MDT? Indian J Dermatol Venereol Leprol, 1996; 62: 45-46.
18. Hu LF, Lu JS, Jian DM et al. Clinical analysis of 111 leprosy patients with type 1 reaction. China J Lep Skin Dis, 2000; 2: 132-140.
19. Vijayakumaran P, Manimozhi N, Jesudasan K et al. Incidence of late lepra reaction among multibacillary leprosy patients after MDT. Int J Lepr, 1995; 63: 18-22.